The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. [electronic resource]
Producer: 20041018Description: 1009-1017 p. digitalISSN:- 0003-2999
- 3',5'-Cyclic-AMP Phosphodiesterases -- metabolism
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Biomarkers
- Blood Gas Analysis
- Cardiac Surgical Procedures -- adverse effects
- Cardiopulmonary Bypass -- adverse effects
- Cyclic Nucleotide Phosphodiesterases, Type 3
- Endothelium, Vascular -- physiology
- Enoximone -- therapeutic use
- Female
- Glutathione Transferase -- metabolism
- Heart Rate -- drug effects
- Hemodynamics -- drug effects
- Humans
- Inflammation -- metabolism
- Kidney Function Tests
- Male
- Monitoring, Intraoperative
- Myocardial Ischemia -- metabolism
- Phosphodiesterase Inhibitors -- therapeutic use
- Postoperative Complications -- pathology
- Propanolamines -- therapeutic use
- Splanchnic Circulation -- physiology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.